Advances in nanotechnology have had profound impacts on therapeutic delivery, leading to
the development of nanomaterials engineered with large carrying capabilities and targeting …

In recent years, there have been a plethora of nanoengineering approaches for the
development of poly (lactide‐co‐glycolide)(PLGA) nanoparticulate carrier systems …

Nanoscale drug delivery systems for cancer treatment have demonstrated promising results
in enhancing the selectivity of therapeutic agents while reducing their toxic side effects …

Nanoparticle technology is being incorporated into many areas of molecular science and
biomedicine. Because nanoparticles are small enough to enter almost all areas of the body …

Multivalent binding, the simultaneous binding of multiple ligands to multiple receptors, has
played a central role in a number of pathological processes, including the attachment of …

The barrier functions of the stratum corneum and the epidermal layers present a tremendous
challenge in achieving effective transdermal delivery of drug molecules. Although a few …

Nanoparticle (NP)-based drug delivery platforms have received a great deal of attention
over the past two decades for their potential in targeted cancer therapies. Despite the …

Several novel, innovative approaches for improving transdermal delivery of BCS class III
drugs have been proposed. Despite their great aqueous solubility, BCS class III drugs have …

Dendrimers comprise a specific group of macromolecules, which combine structural
properties of both single molecules and long expanded polymers. The three-dimensional …

Several novel, innovative approaches for improving transdermal delivery of BCS class III
drugs have been proposed. Despite their great aqueous solubility, BCS class III drugs have …